<DOC>
	<DOC>NCT01282138</DOC>
	<brief_summary>The purpose of this study was to evaluate ocular responses with different allergen provocation methods.</brief_summary>
	<brief_title>Assessment of Alcon's Ocular Image Quantification System</brief_title>
	<detailed_description>Subjects demonstrating a successful allergen response to a common allergen received the first study treatment and used as instructed for 5 days, after which they entered the Environmental Exposure Chamber (EEC) for a 3-hour exposure to a known concentration of the allergen. After waiting at least 7 days, subjects received the second study treatment and used as instructed for 5 days, after which a 3-hour Conjunctival Allergen Provocation Test (CAPT) was performed with an escalating concentration of the allergen. Subjects dosed with study treatment approximately 15 minutes prior to each allergen provocation test.</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Allergic</mesh_term>
	<mesh_term>Dextrans</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>History of allergic conjunctivitis; Active signs and symptoms of ocular allergies; Other protocoldefined inclusion criteria may apply. History of dry eye; Presence of ocular infection; Presence of severe or serious ocular conditions; Symptoms of allergic conjunctivitis; Use of topical or systemic ocular medications as specified in protocol; Ocular surgery or laser surgery within 6 months of study start; Unwilling to discontinue contact lens wear 72 hours prior to Visit 1 and during study period; Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Allergic conjunctivitis</keyword>
</DOC>